期刊文献+

血浆循环microRNA-126在非小细胞肺癌诊断中的应用 被引量:4

Application of plasma circulation microRNA-126 to diagnosis of non-small cell lung cancer
下载PDF
导出
摘要 目的探讨血浆循环microRNA-126浓度与非小细胞肺癌(NSCLC)的相关性及其诊断价值。方法采用实时荧光定量PCR方法检测130例NSCLC患者和作为对照的170例健康人的血浆循环microRNA-126浓度。结果对照组血浆循环microRNA-126浓度显著高于NSCLC组(P<0.01)。血浆循环microRNA-126浓度ROC曲线下面积(area under theROC curve,AUC)为0.758,95%CI为0.704~0.811(P<0.01)。当血浆microRNA-126浓度为1051 fmol/L时,血浆microRNA-126对NSCLC诊断的特异度为90.0%,灵敏度为46.4%。其浓度与患者的年龄、性别、吸烟,病理分型和分期均无显著的相关性(P>0.05)。结论血浆循环microRNA-126浓度对NSCLC有一定的临床诊断意义,联合其他血浆microRNA或肿瘤标志物,如神经元特异性烯醇化酶、癌胚抗原和细胞角蛋白片段21-1,可以弥补单一检测的局限性,以提高肺癌的阳性检出率,为临床提供可靠的依据。 Objective To discuss the correlation between the concentration of plasma circulation microRNA-126 and the non-small cell lung cancer(NSCLC),and to study its diagnostic value.Methods The concentration of plasma circulation micro RNA-126 in 130 patients with NSCLC(NSCLC group)and 170 healthy people(control group)was detected through the method of real time fluorescent quantitation PCR.Results The concentration of microRNA-126 in the control group was significantly higher than that in the NSCLC group(P0.01).The area under the receiver operating characteristic curve of the concentration was 0.758,and the 95% CI was 0.704-0.811(P0.01).When the concentration of plasma microRNA-126 was 1051 fmol/L,its specificity in the diagnosis of NSCLC was 90%,and its sensitivity was 46.4%.There were not obvious correlations between the concentration and age,gender,smoking,pathological typing and staging of the 130 patients.Conclusion The concentration of plasma circulation microRNA-126 has certain significance in the diagnosis of NSCLC.Combined with other plasma microRNA or tumor markers,such as neuron-specific enolase,carcino-embryonic antigen and cytokeratin fragment 21-1,it can retrieve the limitations of the simple detection,increase the positive detection rate of lung cancer and provide dependable data for clinical diagnosis.
作者 刘沙 杨季云
出处 《西南国防医药》 CAS 2011年第12期1280-1283,共4页 Medical Journal of National Defending Forces in Southwest China
基金 国家自然科学基金(30800633) 四川省杰出青年基金(09ZQ026-034)
关键词 非小细胞肺癌 循环microRNA-126 实时荧光定量PCR non-small cell lung cancer circulation microRNA-126 real time fluorescent quantitation PCR
  • 相关文献

参考文献1

二级参考文献20

  • 1Duffy MJ. Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38:225-262.
  • 2Thomas CM, Sweep CG. Serum tumor markers: past, state of the art, and future, lnt J Biol Markers 2001; 16:73-86.
  • 3Duffy MJ. Role of tumor markers in patients with solid cancers: a critical review. Eur J lntern Med 2007; 18:175-184.
  • 4Roulston JE. Limitations of tumour markers in screening. Br J Surg 1990; 77:961-962.
  • 5Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.
  • 6Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866.
  • 7Chen C, Ridzon DA, Broomer A J, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179.
  • 8Tang F, Hajkova P, Barton SC, Lao K, Surani MA. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 2006; 34:e9.
  • 9Hafner M, Landgraf P, Ludwig J, et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 2008; 44:3-12.
  • 10Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103:2257-2261.

共引文献977

同被引文献37

  • 1Siegel R,DeSantis C,Virgo K,et al.Cancer treatment and survivorship statistics,2012[J].CA Cancer J Clin,2012,62(4):220-241.
  • 2Friedman RC,Farh KK,Burge CB,et al.Most mammalian mRNAs are conserved targets of microRNAs[J].Genome Res,2009,19(1):92-105.
  • 3Xi Y,Nakajima G,Gavin E,et al.Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples[J].RNA,2007,13(10):1668-1674.
  • 4Ng EK,Chong WW,Jin H,et al.Differential expression of microRNAs in plasma of patients with colorectal cancer:a potential marker for colorectal cancer screening[J].Gut,2009,58(10):1375-1381.
  • 5Wong TS,Liu XB,Wong BY,et al.Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue[J].Clin Cancer Res,2008,14(9):2588-2592.
  • 6Lin Q,Chen T,Lin Q,et al.Serum miR-19a expression correlates with worse prognosis of patients with non-small cell lung cancer[J].J Surg Oncol,2013,107(7):767-771.
  • 7Xie Y,Todd NW,Liu Z,et al.Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer[J].Lung Cancer,2010,67(2):170-176.
  • 8Xing L,Todd NW,Yu L,et al.Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers[J].Mod Pathol,2010,23(8):1157-1164.
  • 9Yu L,Todd NW,Xing L,et al.Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers[J].Int J Cancer,2010,127(12):2870-2878.
  • 10Zhang JG,Wang JJ,Zhao F,et al.MicroRNA-21(miR-21)represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer(NSCLC)[J].Clin Chim Acta,2010,411(11-12):846-852.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部